219 related articles for article (PubMed ID: 10698982)
21. Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation.
Odds FC; Vranckx L; Woestenborghs F
Antimicrob Agents Chemother; 1995 Sep; 39(9):2051-60. PubMed ID: 8540715
[TBL] [Abstract][Full Text] [Related]
22. Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp.
Pfaller MA; Diekema DJ; Procop GW; Rinaldi MG
J Clin Microbiol; 2007 Nov; 45(11):3522-8. PubMed ID: 17913927
[TBL] [Abstract][Full Text] [Related]
23. In-vitro susceptibility testing by agar dilution method to determine the minimum inhibitory concentrations of amphotericin B, fluconazole and ketoconazole against ocular fungal isolates.
Therese KL; Bagyalakshmi R; Madhavan HN; Deepa P
Indian J Med Microbiol; 2006 Oct; 24(4):273-9. PubMed ID: 17185846
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Etest and macrodilution broth method for antifungal susceptibility testing of Candida sp strains isolated from oral cavities of AIDS patients.
Silva Mdo R; Costa MR; Miranda AT; Fernandes Ode F; Costa CR; Paula CR
Rev Inst Med Trop Sao Paulo; 2002; 44(3):121-5. PubMed ID: 12163903
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.
Pfaller MA; Barry AL
J Clin Microbiol; 1994 Aug; 32(8):1992-6. PubMed ID: 7989555
[TBL] [Abstract][Full Text] [Related]
26. [Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents].
de Montclos M; de Montclos H; Flandrois JP
Pathol Biol (Paris); 1992 May; 40(5):495-9. PubMed ID: 1495833
[TBL] [Abstract][Full Text] [Related]
27. Comparative evaluation of Sensititre YeastOne vs. the NCCLS M27A protocol and E-test for antifungal susceptibility testing of yeasts.
Lombardi G; Farina C; Andreoni S; Fazii P; Faggi E; Pini G; Manso E; Nanetti A; Mazzoni A
Mycoses; 2004 Oct; 47(9-10):397-401. PubMed ID: 15504123
[TBL] [Abstract][Full Text] [Related]
28. Rapid flow cytometric susceptibility testing of Candida albicans.
Ramani R; Ramani A; Wong SJ
J Clin Microbiol; 1997 Sep; 35(9):2320-4. PubMed ID: 9276410
[TBL] [Abstract][Full Text] [Related]
29. [Antifungal susceptibility of clinically isolated Candida albicans by broth microdilution method].
Yamazumi T; Kuroda T; Ohata T; Obana Y; Furuta I
Kansenshogaku Zasshi; 1998 Aug; 72(8):813-9. PubMed ID: 9780584
[TBL] [Abstract][Full Text] [Related]
30. Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing.
Pfaller MA; Arikan S; Lozano-Chiu M; Chen Y; Coffman S; Messer SA; Rennie R; Sand C; Heffner T; Rex JH; Wang J; Yamane N
J Clin Microbiol; 1998 Sep; 36(9):2609-12. PubMed ID: 9705401
[TBL] [Abstract][Full Text] [Related]
31. Determination of minumum inhibitory concentrations of Candida species isolated from vaginal swab specimens by using broth macrodilution and E-test.
Birinci A; Saniç A; Durupinar B
J Chemother; 2001 Feb; 13(1):43-6. PubMed ID: 11233799
[TBL] [Abstract][Full Text] [Related]
32. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
33. Antifungal susceptibility of Candida isolates at the American University of Beirut Medical Center.
Araj GF; Daher NK; Tabbarah ZA
Int J Antimicrob Agents; 1998 Nov; 10(4):291-6. PubMed ID: 9916903
[TBL] [Abstract][Full Text] [Related]
34. Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
Dannaoui E; Paugam A; Develoux M; Chochillon C; Matheron J; Datry A; Bouges-Michel C; Bonnal C; Dromer F; Bretagne S
Clin Microbiol Infect; 2010 Jul; 16(7):863-9. PubMed ID: 19778296
[TBL] [Abstract][Full Text] [Related]
35. Effect of pH and buffer system on the in-vitro activity of five antifungals against yeasts.
Gadea I; Cuenca M; Gegúndez MI; Zapardiel J; Valero ML; Soriano F
J Antimicrob Chemother; 1997 Apr; 39(4):453-9. PubMed ID: 9145817
[TBL] [Abstract][Full Text] [Related]
36. [Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].
Yamane N; Igari J
Rinsho Byori; 1997 Feb; 45(2):190-9. PubMed ID: 9121005
[TBL] [Abstract][Full Text] [Related]
37. Fluconazole and amphotericin B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method compared with E-test and semiautomated broth microdilution test.
van Eldere J; Joosten L; Verhaeghe V; Surmont I
J Clin Microbiol; 1996 Apr; 34(4):842-7. PubMed ID: 8815094
[TBL] [Abstract][Full Text] [Related]
38. Effects of antifungal pretreatment on the susceptibility of Candida albicans to human leukocytes.
Mínguez Mínguez F; Lima JE; García MT; Prieto J
Chemotherapy; 1997; 43(5):346-51. PubMed ID: 9309368
[TBL] [Abstract][Full Text] [Related]
39. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures.
Tan GL; Peterson EM
J Clin Microbiol; 2005 Apr; 43(4):1727-31. PubMed ID: 15814992
[TBL] [Abstract][Full Text] [Related]
40. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
